Phosphorylation and small ubiquitin-like modifier (SUMO) conjugation contribute to the spatial and temporal regulation of substrates containing phosphorylation-dependent SUMO consensus motifs (PDSMs). Myocyte-enhancement factor 2 (MEF2) is a transcription factor and PDSM substrate whose modification by SUMO drives postsynaptic dendritic differentiation. NMR analysis revealed that the human SUMO E2 interacted with model substrates for phosphorylated and nonphosphorylated MEF2 in similar extended conformations. Mutational and biochemical analysis identified a basic E2 surface that enhanced SUMO conjugation to phosphorylated PDSM substrates MEF2 and heat-shock transcription factor 1 (HSF1), but not to nonphosphorylated MEF2 or HSF1, nor the non-PDSM substrate p53. Mutant ubiquitin-conjugating enzyme UBC9 isoforms defective in promoting SUMO conjugation to phosphorylated MEF2 in vitro and in vivo also impair postsynaptic differentiation in organotypic cerebellar slices. These data support an E2-dependent mechanism that underlies phosphorylation-dependent SUMO conjugation in pathways that range from the heat-shock response to nuclear hormone signaling to brain development.
a r t i c l e s Many signal-transduction pathways rely on reversible chemical modifications to relay information within and across cells. Signal transduction can be mediated via covalent modification of protein substrates by the ubiquitin-like protein SUMO 1 in processes that contribute to diverse cellular functions such as nuclear transport, cytokinesis, chromosome segregation and transcriptional regulation, among many others 2, 3 . Although SUMO conjugation contributes to the regulation of many pathways, the mechanisms that control when and where SUMO modification occurs on any particular substrate remain poorly understood.
SUMO conjugation shares mechanistic similarities with the ubiquitin-conjugation system, and both use a cascade of factors that include E1-activating enzymes, E2-conjugating enzymes and E3 ligases [4] [5] [6] . Whereas the ubiquitin pathway includes dozens of E2s, the SUMO pathway involves only one E2, UBC9 (ref. 7) . As such, UBC9 represents a crucial node in the SUMO pathway, because it interacts with and catalyzes conjugation to all SUMO targets identified to date. Some SUMO substrates interact with UBC9 through a consensus sequence, ψ-K-x-E [8] [9] [10] [11] [12] (where ψ is a hydrophobic amino acid, K is the lysine to which SUMO is attached, x is any amino acid and E is an acidic residue), whereas other SUMO substrates require a SUMO E3 ligase or SUMO-interacting motif (SIM) to enhance conjugation to SUMO consensus sites or redirect conjugation to nonconsensus sites [13] [14] [15] [16] [17] .
An extended consensus sequence, ψ-K-x-E-x-x-S-P, was recently identified in several proteins that are substrates for both SUMO conjugation and proline-directed kinases 18, 19 (Fig. 1a) . Because phosphorylation of the serine residue leads to increased levels of the SUMO conjugation 20 , this extended SUMO consensus site has been coined the PDSM, for phosphorylation-dependent SUMO motif 21 . The PDSM was initially identified in mammalian heat-shock factors (HSFs) and subsequently identified in several other proteins, including the transcription factors MEF2, GATA1 and peroxisome proliferator-activated receptor-γ (PPARγ) [21] [22] [23] (Fig. 1b) . In these cases, kinase signaling regulates SUMO modification of substrates that contain these extended PDSM sequences.
MEF2 proteins are transcription factors that are abundantly expressed in the mammalian brain during synaptogenesis 24 . SUMO modification converts MEF2A from a transcriptional activator to a transcriptional repressor form that promotes synapse maturation in neurons 23, 25 . SUMO-modified MEF2A drives postsynaptic dendritic differentiation in the cerebellar cortex in a process characterized by morphogenesis of claw-like structures at the termini of granule neuron dendrites. Granule neuron dendritic claws house sites of synaptic contact with mossy fiber terminals and Golgi neuron axons 23 . SUMO modification of MEF2A occurs primarily on a lysine residue that is part of a PDSM (Fig. 1b) , a site highly conserved from Caenorhabditis elegans to humans 23 . These data suggest an important functional link between phosphorylation, SUMO conjugation and biological functions for MEF2.
Although SUMO conjugation is enhanced in response to PDSM phosphorylation, the molecular basis for this effect remains unclear 21, [26] [27] [28] . In the present study, we examined SUMO conjugation to the human PDSM substrates MEF2 and HSF1, in their phosphorylated and nonphosphorylated forms. Our biochemical studies indicate that phosphorylation-dependent SUMO conjugation is E2-dependent, and NMR titration experiments suggest that phosphorylated and nonphosphorylated MEF2 substrates interact with UBC9 a r t i c l e s in an extended conformation that is similar to that observed for other UBC9-substrate complexes. Inspection of the UBC9 structure suggests that the Lys65, Lys74 and Lys76 side chains compose a positively charged or basic patch that could interact with the negatively charged phosphorylated serine side chain. Site-directed mutagenesis coupled with biochemical and kinetic analysis reveal that this E2 surface is important for enhanced SUMO conjugation to phosphorylated MEF2 and HSF1 substrates, but not for conjugation to nonphosphorylated MEF2 or HSF1, nor to the non-PDSM substrate p53. Mutations in UBC9 that disrupt PDSM discrimination in vitro also disrupt SUMO modification of phosphorylated MEF2 substrates in transient transfection assays in vivo. Functional analysis of the UBC9 mutations that disrupted PDSM modification of MEF2 in assays of dendritic claw development in organotypic cerebellar slices reveal a strong correlation between UBC9 activities in vitro and those observed in vivo.
RESULTS

PDSM phosphorylation enhances E2-dependent conjugation
To identify components of the SUMO-conjugation pathway that are responsive to phosphorylation within PDSM sequences, we began our analysis with two well-defined and homogenous 20-amino-acid MEF2 peptide substrates. One contained the nonphosphorylated extended SUMO consensus motif (MEF2) and the other contained the MEF2A PDSM in which Ser408 was phosphorylated (MEF2 P ) ( Fig. 1a,b ). Biochemical analysis of E2-mediated conjugation under conditions of multiple turnover suggested that the phosphorylated MEF2 was a better substrate for SUMO conjugation ( Supplementary  Fig. 1 ). We used MS to confirm SUMO conjugation to the consensus lysine residues in both substrates (data not shown).
We conducted reactions under conditions of single turnover, which enabled calculation of the apparent binding (K d ) and rate (k 2 ) constants. We found that MEF2 P was a better substrate than MEF2 for wild-type UBC9 ( Fig. 1c and Supplementary  Fig. 1 ), and at room temperature (23 °C) the apparent K d and k 2 for MEF2 P were 240 ± 30 µM and 0.054 ± 0.002 s −1 , respectively, whereas the K d and k 2 for MEF2 were 440 ± 60 µM and 0.010 ± 0.001 s −1 , respectively. Wild-type UBC9 showed a ten-fold higher specificity constant (k 2 /K d ) for MEF2 P (230 ± 30 M −1 s −1 ) compared to MEF2 (23 ± 4 M −1 s −1 ) ( Fig. 1c and Table 1 ). In this case, binding was affected by a two-fold difference, whereas rates differed by five-fold. Because binding was less affected than the rate constants, these data suggest that the phosphorylated substrate may interact with UBC9 in a slightly different but more favorable conformation to facilitate catalysis within the E2 active site. Precise positioning of the lysine residue within the SUMO E2 active site was previously shown to have an important role during conjugation, primarily through altering the catalytic rate 12 . We envision a similar mechanism underlying the observed effects in the present case.
The preference we observed for conjugation to the phosphorylated substrate in vitro was similar to that observed in vivo without overexpression of UBC9 (ref. 23 and Fig. 1d ). As such, there is at present no reason to invoke an E3 in the process of discriminating PDSM phosphorylation status. Data consistent with this hypothesis include the observation that the SUMO E3 PIASx interacts with MEF2A independently of Ser408 phosphorylation 25 . Although wild-type MEF2A showed increased SUMO conjugation in the presence of exogenous PIASx, SUMO conjugation was still dependent on phosphorylation, suggesting that PDSM discrimination occurred in a manner dependent on the specificity of the E2. In other words, phosphorylation was important for SUMO conjugation independently of whether PIASx was absent or present in cells 25 . As further evidence that the process is E2-dependent, the SUMO E3 IR1* domain of Nup358 (also known as RanBP2) increased conjugation to both substrates in vitro, and the preference for phosphorylated MEF2 was maintained at a similar ratio to that observed in E2-mediated reactions (Supplementary Fig. 2 ).
UBC9 binds MEF2 P and MEF2 in similar conformations
We carried out uniform 15 N labeling of human UBC9 and used it in isolation to obtain nearly complete assignments for nonproline residues, based on previously deposited assignments 10 (see Online Methods and Additional examples for a subset of raw data used in constructing plots in the kinetic analysis is provided in Supplementary Figure 1 . Below, a plot is shown (left) for the initial rates of reaction versus substrate concentration, and a bar chart (right) of the plot indicates individual specificity constants (k 2 /K d ) for wild-type UBC9-mediated SUMO conjugation to MEF2 P (red) and MEF2 (black). The bar chart (right) indicates the fold preference for MEF2 P (gray) expressed as MEF2 P (k 2 /K d )/MEF2(k 2 /K d ).
(d) HA-SUMO1 conjugation to wild-type GAL4-MEF2A and GAL4-MEF2A-S408A in 293T cells. Left, GAL4 immunoprecipitates (IP) of 293T cells transfected with HA-SUMO1 and wild-type, K403R or S408A mutant GAL4-MEF2A were immunoblotted (IB) using the indicated antibodies. Below is an immunoblot of the total lysate using anti-tubulin antibody (as loading control). Right, bar chart indicating 4.08 ± 1.48 enhancement for HA-SUMO1 modification to wild-type GAL4-MEF2A compared to GAL4-MEF2A-S408A, calculated as described in Online Methods. Biochemical assays were conducted in triplicate. Error bars are 1 s.d.
a r t i c l e s Supplementary Fig. 3 ). We then assessed NMR chemical shift perturbations for UBC9 in the presence of increasing concentrations of the nonphosphorylated and phosphorylated MEF2 substrates ( Supplementary  Fig. 3 ). Chemical shift perturbations for both MEF2 and MEF2 P map to UBC9 surfaces known to be important for recognition of substrates containing SUMO consensus sites (Supplementary Figs. 3-5 ), including complexes between UBC9 and RanGAP1 obtained from crystallographic studies 9, 11, 12 , as well as complexes between UBC9 and peptide models for p53 and c-Jun, as determined by NMR solution studies and biochemical analysis 9,10,12 . These data suggest that nonphosphorylated and phosphorylated MEF2 substrates adopt similar extended conformations to those observed for other UBC9 substrates.
Comparing UBC9 chemical shift perturbations in the presence of MEF2 or MEF2 P revealed few differences within and adjacent to previously characterized E2-binding surfaces for substrates that contain SUMO consensus sites ( Supplementary Figs. 4 and 5) . When we compared UBC9-MEF2 and UBC9-MEF2 P chemical shift differences, we observed some of the largest differences for Ala5, Asp66, Cys75, Ser89, Val92, Leu94 and Tyr134. Val92 and Leu94 are located immediately adjacent to the UBC9 E2 active site cysteine (Cys93), whereas Tyr134 is proximal to the binding site for the hydrophobic side chain in the SUMO ψ-K-x-E consensus motif. Ser89 is part of a hydrophilic and positively charged pocket that includes Thr91 and Lys74 ( Fig. 2a,b) . These amino acid side chains participate in hydrogen bonding interactions with the SUMO consensus motif glutamate side chain, as observed in structures of UBC9 in complex with RanGAP1. Although the magnitude of chemical shifts differed somewhat between UBC9-MEF2 and UBC9-MEF2 P , we observed no changes in direction for chemical shift perturbations of residues involved in substrate binding. These data suggest that the Ψ-K-x-E SUMO motif in MEF2 PDSM substrates occupies similar binding pockets on the surface of UBC9, independently of the subtrates' phosphorylation status.
The glutamate side chain in SUMO ψ-K-x-E consensus motifs is coordinated by Ser89 and Thr91 (refs. 9,12). Because the phosphorylated serine side chain and glutamate are both negatively charged, we reasoned that the glutamate side chain-binding pocket might coordinate the phosphorylated PDSM serine side chain if it displaced the glutamate side chain upon binding. To test this hypothesis, we substituted Ser89 or Thr91 to alanine and assayed these mutant isoforms for their ability to distinguish PDSM phosphorylation status. UBC9-S89A and UBC9-T91A showed reduced SUMO conjugation to both MEF2 substrates, although UBC9-T91A maintained a ~three-fold preference for MEF2 P , whereas UBC9-S89A maintained a ~14-fold preference for MEF2 P (Supplementary Fig. 2 ).
PDSM discrimination requires the UBC9 basic patch in vitro
NMR analysis did not reveal the precise identity of the UBC9 residues responsible for PDSM discrimination, so we examined the UBC9 structure for residues that flank the active site and SUMO consensus motif-binding pocket. Side chains of Lys65, Lys74 and Lys76 form a positively charged patch on the UBC9 surface 7-12 Å from the glutamate within the extended ψ-K-x-E consensus motif, a suitable distance from the E2 active site to mediate complementary interactions with a phosphorylated serine side chain if the PDSM adopted a somewhat, but not fully, extended conformation (model presented in Fig. 2) .
We generated individual alanine substitution mutants for Lys65, Lys74 and Lys76 and assayed them for activity. UBC9-K74A and UBC9-K76A showed a two-to four-fold decrease in activity for a r t i c l e s modification of the nonphosphorylated MEF2 substrate, whereas UBC9-K65A maintained activities similar to that of wild-type UBC9. When we assayed UBC9-K65A, UBC9-K74A and UBC9-K76A for SUMO conjugation to the phosphorylated MEF2 substrate, the specificity constants remained low and near to those obtained with the nonphosphorylated substrate ( Fig. 3a-c and Supplementary Fig. 1) . These data suggest that UBC9-K65A and UBC9-K74A lost the ability to discriminate between MEF2 P and MEF2 such that the preference for MEF2 P was reduced from 10-fold for wild-type UBC9 to 0.9-fold for UBC9-K65A and 0.6-fold for UBC9-K74A. UBC9-K76A also lost most of its ability to discriminate between substrates, although it maintained a 2.0-fold preference for MEF2 P ( Table 1) . We determined that the Nup358-RanBP2 IR1* SUMO E3 could not rescue defects observed for UBC9-K65A with the MEF2 P substrate ( Table 2 and Supplementary Figs. 1 and 2) .
Next we turned our attention to the ELK1 SUMO consensus motif, which includes a ψ-K-x-E SUMO-conjugation site followed by three acidic residues (Fig. 1b) . This motif was coined the negatively charged amino acid-dependent SUMO-conjugation motif (NDSM) 28 . NDSM and PDSM sequences include negatively charged elements C-terminal to the ψ-K-x-E SUMO consensus site; thus, acidic residues in NDSM substrates may substitute for the phosphorylated serine side chain in PDSMs to maintain a constitutively active motif for SUMO conjugation. Previous reports identified UBC9 Lys59 and Arg61 as residues that contributed to recognition of NDSM within the ELK1 transcription factor 28 , insofar as substitution of Lys59 and Arg61 to glutamate diminished SUMO-conjugation activity. These UBC9 surfaces were also suggested to have a role in SUMO modification of MEF2A 28 .
We found that Lys59 and Arg61 side chains did not contribute to PDSM discrimination, in that UBC9-K59A and UBC9-R61A maintained higher levels of conjugation to the MEF2 P substrate when compared to the MEF2 substrate ( Fig. 3d, Table 1 and Supplementary Figs. 1 and 6) . These results are consistent with the fact that Lys59 and Arg61 are too far from the E2 substratebinding surface to facilitate simultaneous interaction with the ψ-K-x-E SUMO consensus site and phosphorylated serine residue, even if the PDSM adopted a fully extended conformation (Fig. 2) . Previous results used simultaneous glutamate substitution for Lys59 and Arg61 (ref. 28) , and we predict that glutamate substitutions in these positions might substansially alter the properties of UBC9 because of Arg61's involvement in salt-bridging interactions with Glu41 and Glu78 and hydrogen bonding interactions with Asn39 ( Fig. 2 and Supplementary Fig. 6 ). Together, these results indicate that the basic surface on UBC9 formed by Lys65, Lys74 and Lys76 is important for PDSM discrimination of the MEF2A substrate in vitro (Fig. 3e) .
To test whether this UBC9 surface also has a role in discriminating between phosphorylated and nonphosphorylated forms of another PDSM substrate, we performed a similar kinetic analysis with model substrates for HSF1 ( Fig. 1b) , the primary transcription factor responsible for the transcriptional response to heat stress in a r t i c l e s mammalian cells. Similar to results observed for MEF2A, wildtype UBC9 showed an eight-fold preference for phosphorylated HSF1 compared to the nonphosphorylated substrate ( Fig. 4a and Table 1 ). UBC9-K65A maintained nearly wild-type activity for nonphosphorylated HSF1, although it lost its preference for phosphorylated HSF1. (Fig. 4b and Table 1 ). These results are similar to those obtained for MEF2 and MEF2 P and suggest that UBC9 Lys65 contributes to discrimination of PDSM phosphorylation status in vitro for both MEF2A and HSF1. Notably, MEF2A and HSF1 share no sequence conservation outside their respective PDSM sequences ( Fig. 1b) , suggesting that the PDSM element is sufficient to mediate interactions with the E2. Our biochemical analysis revealed that wild-type UBC9 and UBC9-K65A have comparable rates of SUMO conjugation to MEF2A and HSF1 in their nonphosphorylated state (Figs. 1c, 3a and 4b) . Because the Lys65 side chain was not important for interactions with a nonphosphorylated PDSM substrate, we hypothesized that this side chain would not contribute to SUMO conjugation of substrates containing a simple SUMO consensus motif. To test this, we conducted singleturnover SUMO-conjugation assays with a non-PDSM substrate, in this case the C-terminal domain of p53. Comparison of the conjugation activities catalyzed by wild-type UBC9 and UBC9-K65A revealed similar rates of SUMO conjugation to p53 (refs. 11,12) (Figs. 4c,d and Table 1 ). Thus, UBC9-K65A had no discernable effect on SUMO conjugation to a non-PDSM containing substrate, nor to MEF2A or HSF1 in their nonphosphorylated state.
Because PDSM and acidic NDSM SUMO-conjugation motifs share similar negative electrostatic properties C-terminal to the SUMO ψ-K-x-E motif (Fig. 1b) , we next compared UBC9-K59A and UBC9-K65A in conjugation reactions with a model ELK1 substrate to determine whether these side chains contributed to interaction with an NDSM substrate (see Online Methods and Supplementary  Fig. 7) . Our data revealed a mild two-fold decrease in the specificity constant for UBC9-K65A when compared to wild-type UBC9 for SUMO conjugation to ELK1 ( Table 2) . When we assessed UBC9-K59A, the specificity constant was similar to that obtained for UBC9-K65A ( Table 2 ). These data suggest that Lys65 contributes less to recognition of NDSM substrates such as ELK1 in comparison to its role in discriminating between phosphorylated states of either MEF2 or HSF1 PDSM substrates.
PDSM discrimination requires the UBC9 basic patch in vivo
We next explored the effects of UBC9 amino acid substitutions that abrogated PDSM discrimination in vitro through transfection assays in 293T cells, by exogenous expression of hemagglutinin (HA)-tagged SUMO1 or SUMO2, Myc-tagged UBC9 or its respective mutant alleles, and GAL4-tagged MEF2A (see Online Methods). In comparison to cells not expressing exogenous UBC9, expression of the respective mutant UBC9 proteins led to an increase in levels of SUMO conjugates independently of whether HA-SUMO1 or HA-SUMO2 was expressed (Fig. 5a) . These data suggest that each UBC9 isoform was capable of recognizing the bulk of SUMO substrates in the cell, irrespective of the point mutation tested. Although we observed some differences in the levels of SUMO conjugates in cells expressing exogenous Myc-UBC9 isoforms, expression of each Myc-UBC9 mutant isoform led to higher levels of SUMO conjugates compared to cells expressing HA-SUMO1 or HA-SUMO2 in the presence of endogenous UBC9 (vector control for expression of exogenous Myc-UBC9; Fig. 5a) .
Previous studies demonstrated that approximately half of exogenously expressed GAL4-MEF2A is phosphorylated on Ser408 (ref. 23 ). In cells not expressing exogenous Myc-UBC9, HA-SUMO1 conjugation to GAL4-MEF2A was enhanced by approximately five-fold when compared to HA-SUMO1 conjugation to GAL4-MEF2A-S408A, a substrate incapable of phosphorylation at Ser408 (Fig. 1d) . When exogenous Myc-tagged wild-type UBC9 (Myc-UBC9-WT) was expressed, HA-SUMO1 conjugation was enhanced for both substrates. In this case, HA-SUMO1 conjugation was approximately nine-fold higher in cells expressing GAL4-MEF2A in comparison to those expressing GAL4-MEF2A-S408A (compare Fig. 1d with Fig. 5b) .
We next assessed Myc-UBC9-K65A, Myc-UBC9-K74A, Myc-UBC9-K76A and Myc-UBC9-K59A for their ability to distinguish MEF2A PDSM phosphorylation status in vivo. Consistent with activities a r t i c l e s observed in vitro, expression of Myc-UBC9-K65A and Myc-UBC9-K74A led to selective loss of HA-SUMO1-conjugated GAL4-MEF2A when compared to GAL4-MEF2A-S408A, whereas expression of Myc-UBC9-K76A maintained an approximately two-fold preference for GAL4-MEF2A in comparison to GAL4-MEF2A-S408A (Fig. 5b) .
In contrast, Myc-UBC9-K59A was comparable to Myc-UBC9-WT with respect to its ability to discriminate between GAL4-MEF2A and GAL4-MEF2A-S408A (compare Fig. 1d with Fig. 5b) .
To a first approximation, data obtained in vivo echo data obtained in vitro for UBC9, UBC9-K65A, UBC9-K74A, UBC9-K76A and UBC9-K59A, in several respects: (i) UBC9-K65A lost the ability to discriminate between PDSM phosphorylation status but maintained the ability to conjugate SUMO at nearly wild-type levels to GAL4-MEF2A-S408A. (ii) UBC9-K74A lost the ability discriminate between substrates but had lower conjugation activity for both GAL4-MEF2A and GAL4-MEF2A-S408A. (iii) UBC9-K76A maintained a slight preference for GAL4-MEF2A in comparison to GAL4-MEF2A-S408A; (iv) the UBC9-K59A side chain was not important for discriminating PDSM phosphorylation status. Because we did not observe global defects for HA-SUMO1 conjugation in whole-cell extracts (Fig. 5a) , we suggest that defects observed for HA-SUMO1 conjugation to GAL4-MEF2A are due to the inability of the respective UBC9 mutant isoform to distinguish the MEF2 PDSM phosphorylation status.
We also examined whether UBC9 mutant isoforms can distinguish MEF2A PDSM phosphorylation status in cells expressing exogenous HA-SUMO2. HA-SUMO2 conjugates of GAL4-MEF2A could not be detected in the presence of endogenous UBC9 (Fig. 5c) , similar to previous observations 29 . However, we did observed modification of GAL4-MEF2A by HA-SUMO2 in the presence of exogenously expressed Myc-UBC9-WT. Additionally, expression of the mutant UBC9 isoforms Myc-UBC9-K65A, Myc-UBC9-K74A and Myc-UBC9-K76A in the presence of HA-SUMO2 led to selective loss of HA-SUMO2-conjugated GAL4-MEF2A compared to GAL4-MEF2A-S408A. Myc-UBC9-K59A maintained its ability to discriminate between GAL4-MEF2A and GAL4-MEF2A-S408A ( Fig. 5c) . Results obtained in transfection experiments with HA-SUMO2 and the respective Myc-UBC9 isoforms are consonant with results obtained with HA-SUMO1.
Because endogenous UBC9 remains present in cells transfected with plasmids encoding the respective Myc-UBC9 alleles, our data suggest that overexpression of Myc-UBC9-K65A, Myc-UBC9-K74A or Myc-UBC9-K76A can suppress SUMO conjugation to GAL4-MEF2A by blocking the activities of endogenous UBC9 by mass action (Myc-UBC9 isoforms were expressed at five-to ten-fold higher levels in comparison to endogenous UBC9; data not shown). As such, exogenously expressed Myc-UBC9 may compete with endogenous UBC9 for activation by the SUMO E1 or binding to its cognate E3, or by blocking endogenous UBC9 from recognizing the phosphorylated MEF2 PDSM.
UBC9 basic patch is important for dendritic morphogenesis
Phosphorylation-dependent SUMO conjugation to MEF2 is required for postsynaptic dendritic morphogenesis in the cerebellar cortex 23, 25 .
To determine whether Lys65, Lys74 or Lys76 side chains contribute to PDSM discrimination in vivo in morphological assays of postsynaptic dendritic claw development, we expressed exogenous Flag-UBC9 and the respective mutant isoforms and assessed their effects on dendritic claw differentiation in the rat cerebellar cortex (Fig. 6) . We prepared cerebellar slices from postnatal day 9 (P9) or Cerebellar slices were fixed and subjected to immunohistochemistry using a GFP antibody to visualize granule neurons in the cerebellar cortex. Claws were frequently present at the ends of granule neuron dendrites in cerebellar slices transfected with the control vector and Flag-UBC9-WT 23, 25 (Fig. 6a, left and middle) . In contrast, cerebellar slices transfected with Flag-UBC9-K65A had markedly fewer granule neuron dendritic claws. Instead, many dendrites of granule neurons expressing Flag-UBC9-K65A frequently showed bulbous or tapered ends (Fig. 6a, right) . As with cerebellar slices transfected with Flag-UBC9-K65A, slices transfected with Flag-UBC9-K74A and Flag-UBC9-K76A also had significantly fewer granule neuron dendrites that harbored claws (P<0.001). Notably, granule neurons in cerebellar slices transfected with Flag-UBC9-K59A had a similar number of dendritic claws as those in slices transfected with Flag-UBC9-WT or the control vector ( Fig. 6b) . As a control for effects of mutations on Flag-UBC9 expression, we also transfected 293T cells with each expression plasmid; however, we observed no appreciable differences (Fig. 6c) .
As in our previous transfection experiments, endogenous UBC9 remains present in neurons transfected with plasmids encoding respective UBC9 alleles. Thus, our data suggest that suppression of dendritic claw differentiation results from a dominant effect on the activities of endogenous UBC9, either through blocking activation by the E1 or by blocking recognition of the phosphorylated MEF2 PDSM in cells overexpressing Flag-UBC9-K65A, Flag-UBC9-K74A and Flag-UBC9-K76A. Notably, overexpression of Flag-UBC9-WT or Flag-UBC9-K59A had no detectable effect on dendritic claw differentiation, suggesting that UBC9 was not a rate-limiting factor during claw differentiation. Taken together, the high correlation (correlation coefficient >0.95) between results for UBC9-catalyzed SUMO conjugation obtained in vitro and effects of UBC9 mutants on dendritic claw differentiation in the cerebellar cortex suggest that UBC9 Lys65, Lys74 and Lys76 have an important role in discriminating between phosphorylated and nonphosphorylated forms of MEF2A in vivo (Fig. 6b) .
DISCUSSION
Phosphorylation-dependent SUMO conjugation integrates two important signal-transduction pathways. Using biochemical, structural and biological analysis, we have demonstrated that a conserved basic patch on the UBC9 surface is responsible for UBC9's ability to discriminate between phosphorylated and nonphosphorylated PDSM motifs within MEF2A and HSF1 in vitro and MEF2A in vivo. The present analysis offers a unique perspective on the evolution of SUMO conjugation. Instead of integrating substrate phosphorylation with E3-mediated interactions, as is more commonly observed in the ubiquitin pathway, some SUMO substrates have developed an ability to engage the SUMO E2 at two sites by combining E2 surfaces responsible for recognition of the SUMO consensus motif with surfaces required for recognition of the phosphorylated serine in the PDSM consensus motif.
The phosphorylated serine residue is located just two residues downstream of the glutamate residue in the extended ψ-K-x-E-x-x-S-P SUMO motif, and its position is highly conserved in other substrates containing PDSMs. As the same basic surface on UBC9 seems to be important for PDSM discrimination for both MEF2A (in vitro and in vivo) and HSF1 (in vitro), our data suggest that E2-mediated recognition of other PDSM substrates such as GATA1 and PPARγ would occur in a similar manner. The analysis presented herein for phosphorylation-dependent SUMO conjugation to MEF2A helps to establish a molecular mechanism for E2-dependent conjugation to PDSM-containing substrates, which regulate diverse biological processes including synapse development and plasticity.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
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